Overview
Psoriatic arthritis is a chronic,
inflammatory, seronegative spondyloarthropathy associated with psoriasis, as
stated in the Introduction
section.
The prevalence of psoriatic arthritis in the
general population ranges from 0.1%-1%. A detailed discussion about the
prevalence of psoriatic arthritis is in the Epidemiology
section.
The Pathophysiology section states that psoriatic arthritis
results from an interplay of genetic predisposition, environmental triggers (eg
biomechanical stress, infections, smoking, obesity), local factors according to
disease site (joints, skin, spine, and entheses), and interaction with innate
and adaptive immune responses. The developmental process of psoriatic arthritis
is in this section.
The Risk
Factors section enumerates
the factors that are associated with the development of psoriatic arthritis.
Psoriatic Arthritis_Disease SummaryHistory and Physical Examination
The Clinical Presentation section describes the clinical features seen in patients with psoriatic arthritis.
Diagnosis
The Diagnosis
or Diagnostic Criteria section
features the classification criteria such as the ClASsification of Psoriatic
ARthritis (CASPAR), and the Moll and Wright Criteria.
The Screening
section lists the different questionnaires used for the early detection of
psoriatic arthritis and the specific scales used to assess the quality of life
of patients affected.
Discussion on serologic tests in the diagnosis
of psoriatic arthritis is in the Laboratory
Tests and Ancillaries section.
The Imaging
section discusses the different diagnostic studies that help in the evaluation
of psoriatic arthritis.
Other conditions that should be ruled out in
the diagnosis of psoriatic arthritis are listed in the Differential Diagnosis section.
Management
Discussions on the course of disease of
psoriatic arthritis are in the Evaluation
section. Assessments of the severity of psoriatic arthritis are also included
in this section.
General therapy principles and management of psoriatic
arthritis are in the Principles of Therapy
section.
The Pharmacological
Therapy section discusses in
detail the therapeutic options of patients with psoriatic arthritis.
The Nonpharmacological section includes things to educate the
patient about the management of psoriatic arthritis.
